Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN112300176B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel asymmetric [3+2] cyclization method for high-purity chiral five-membered thiaheterocyclic nucleoside analogues with superior enantioselectivity and scalable yield.